指南与共识主动脉疾病

SVS 胸主动脉腔内修复术治疗降主动脉瘤临床实践指南

Society for Vascular Surgery clinical practice guidelines of thoracic endovascular aortic repair for descending thoracic aortic aneurysms.
指南 / 共识 · J Vasc Surg · 2020-07-03

该指南由血管外科学会制定,适用于胸主动脉腔内修复术(TEVAR)治疗降主动脉瘤及其他降主动脉病变,不涵盖主动脉夹层与创伤。指南强调TEVAR较开放修复术病死率和并发症更低,并围绕围术期影像学检查给出多项强推荐。

要点

  • 疑似症状性胸主动脉瘤或急性主动脉综合征高危患者应紧急行CTA。
  • 考虑TEVAR者需行全主动脉及髂股动脉薄层CTA并评估椎动脉解剖。
  • TEVAR术后1个月、12个月及此后每年终生行增强CT随访。

核心结论

  • 在符合器械说明书使用标准且两种技术均可行的患者中,推荐TEVAR作为择期降主动脉瘤的首选治疗,因其降低并发症、住院时间和短期病死率。
  • 对于降主动脉孤立病变,基于短期和中期病死率改善及并发症减少,TEVAR应作为择期和急诊修复的首选方法。

研究设计与样本

  • 本指南由血管外科学会(SVS)制定,针对TEVAR用于降主动脉瘤及其他降主动脉病变。
  • 指南指出胸主动脉瘤领域整体缺乏高质量证据,但大型单中心经验、行政数据库和荟萃分析一致报告TEVAR优于开放修复。

主要发现

  • 开放修复降主动脉是生理影响大的手术,病死率、截瘫和肾衰竭发生率相对较高。
  • TEVAR因并发症和病死率较低已在很大程度上取代开放修复。
  • 大型单中心经验、行政数据库和荟萃分析一致报告TEVAR优于开放修复,尤其在破裂情况下。

关键数值与推荐

  • 对症状性胸主动脉瘤或急性主动脉综合征高危患者,推荐紧急影像学检查,通常为CTA;推荐等级1(强),证据质量B(中等)。
  • 考虑TEVAR时,推荐行全主动脉及髂、股动脉薄层(≤0.25 mm)CTA,并需头颈部CTA确定椎动脉解剖;推荐等级1(强),证据质量A(高)。
  • 推荐常规使用三维中心线重建软件进行TEVAR的准确病例规划和执行;推荐等级1(强),证据质量B(中等)。
  • 推荐TEVAR后1个月和12个月行增强CT扫描,此后终生每年一次,若1个月时发现内漏或其他异常可考虑更频繁影像学检查;推荐等级1(强),证据质量B(中等)。
  • 在符合器械说明书使用标准且两种技术均可行的患者中,推荐TEVAR作为择期降主动脉瘤的首选方法;推荐等级1(强),证据质量A(高)。

临床怎么用

  • 对疑似症状性胸主动脉瘤或急性主动脉综合征高危患者应尽快行CTA检查以明确诊断并规划手术。
  • TEVAR术前应使用薄层CTA评估全主动脉、髂股动脉及椎动脉解剖,并常规应用三维中心线重建软件进行规划。
  • TEVAR术后按1个月、12个月及每年终生进行增强CT随访,发现内漏等异常时增加复查频率。
  • 在解剖条件允许且符合器械说明书的情况下,优先选择TEVAR治疗择期和急诊降主动脉瘤。

局限性

  • 胸主动脉瘤领域整体缺乏高质量证据,需要更好的比较效果研究。
  • 本指南不讨论主动脉夹层和创伤性损伤的处理,这些内容将在其他SVS文件中讨论。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Thoracic aortic diseases, including disease of the descending thoracic aorta (DTA), are significant causes of death in the United States. Open repair of the DTA is a physiologically impactful operation with relatively high rates of mortality, paraplegia, and renal failure. Thoracic endovascular aortic repair (TEVAR) has revolutionized treatment of the DTA and has largely supplanted open repair because of lower morbidity and mortality. These Society for Vascular Surgery Practice Guidelines are applicable to the use of TEVAR for descending thoracic aortic aneurysm (TAA) as well as for other rarer pathologic processes of the DTA. Management of aortic dissections and traumatic injuries will be discussed in separate Society for Vascular Surgery documents. In general, there is a lack of high-quality evidence across all TAA diseases, highlighting the need for better comparative effectiveness research. Yet, large single-center experiences, administrative databases, and meta-analyses have consistently reported beneficial effects of TEVAR over open repair, especially in the setting of rupture. Many of the strongest recommendations from this guideline focus on imaging before, during, or after TEVAR and include the following: In patients considered at high risk for symptomatic TAA or acute aortic syndrome, we recommend urgent imaging, usually computed tomography angiography (CTA) because of its speed and ease of use for preoperative planning. Level of recommendation: Grade 1 (Strong), Quality of Evidence: B (Moderate). If TEVAR is being considered, we recommend fine-cut (≤0.25 mm) CTA of the entire aorta as well as of the iliac and femoral arteries. CTA of the head and neck is also needed to determine the anatomy of the vertebral arteries. Level of recommendation: Grade 1 (Strong), Quality of Evidence: A (High). We recommend routine use of three-dimensional centerline reconstruction software for accurate case planning and execution in TEVAR. Level of recommendation: Grade 1 (Strong), Quality of Evidence: B (Moderate). We recommend contrast-enhanced computed tomography scanning at 1 month and 12 months after TEVAR and then yearly for life, with consideration of more frequent imaging if an endoleak or other abnormality of concern is detected at 1 month. Level of recommendation: Grade 1 (Strong), Quality of Evidence: B (Moderate). Finally, based on our review, in patients who could undergo either technique (within the criteria of the device's instructions for use), we recommend TEVAR as the preferred approach to treat elective DTA aneurysms, given its reduced morbidity and length of stay as well as short-term mortality. Level of recommendation: Grade 1 (Strong), Quality of Evidence: A (High). Given the benefits of TEVAR, treatment using a minimally invasive approach is largely based on anatomic eligibility rather than on patient-specific factors, as is the case in open TAA repair. Thus, for isolated lesions of the DTA, TEVAR should be the primary method of repair in both the elective and emergent setting based on improved short-term and midterm mortality as well as decreased morbidity.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Upchurch GR, Escobar GA, Azizzadeh A, et al. Society for Vascular Surgery clinical practice guidelines of thoracic endovascular aortic repair for descending thoracic aortic aneurysms. J Vasc Surg. 2020. PMID: 32628988. doi:10.1016/j.jvs.2020.05.076

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。